Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228526 · ClinicalTrials.gov registry record
A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 22
- Enrollment target
NCT01228526 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 22 participants.
The verdict
NCT01228526 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.
Interventions
- DEVICE PriMatrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01228526
The ClinicalTrials.gov registry entry for NCT01228526 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PriMatrix is the first listed.
NCT01228526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01228526 about?
NCT01228526 is a clinical study titled "A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers". To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.
What is the current status of trial NCT01228526?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2010-08. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01228526?
The interventions under investigation include: PriMatrix (DEVICE).
Who is sponsoring clinical trial NCT01228526?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.